Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tretinoin 0.05% cream
1306010V0AAANAN
|
Tretinoin (Acne) | Tretinoin | Skin | 12 |
|
Tretinoin 0.05% gel
1306010V0AAAKAK
|
Tretinoin (Acne) | Tretinoin | Skin | 4 |
|
Tretinoin 0.01% gel
1306010V0AAALAL
|
Tretinoin (Acne) | Tretinoin | Skin | 2 |
|
Tretinoin 0.025% cream
1306010V0AAAEAE
|
Tretinoin (Acne) | Tretinoin | Skin | 2 |
|
Tretinoin 0.025% gel
1306010V0AAAMAM
|
Tretinoin (Acne) | Tretinoin | Skin | 1 |
|
Tretinoin 10mg capsules
0801050X0AAAAAA
|
Tretinoin (Systemic) | Tretinoin | Malignant Disease and Immunosuppression | 1 |
|
Acticin 0.025% cream
1306010V0BDAAAE
|
Acticin | Tretinoin | Skin | No data available |
|
Retin-A 0.01% gel
1306010V0BBADAL
|
Retin-A | Tretinoin | Skin | No data available |
|
Retin-A 0.025% cream
1306010V0BBAEAE
|
Retin-A | Tretinoin | Skin | No data available |
|
Retin-A 0.025% gel
1306010V0BBABAM
|
Retin-A | Tretinoin | Skin | No data available |
|
Retin-A 0.025% lotion
1306010V0BBACAC
|
Retin-A | Tretinoin | Skin | No data available |
|
Retinova 0.05% cream
1308010V0BBAAAA
|
Retinova | Tretinoin | Skin | No data available |
|
Tretinoin 0.025% lotion
1306010V0AAACAC
|
Tretinoin (Acne) | Tretinoin | Skin | No data available |
|
Tretinoin 0.1% gel
1306010V0AAAPAP
|
Tretinoin (Acne) | Tretinoin | Skin | No data available |
|
Vesanoid 10mg capsules
0801050X0BBAAAA
|
Vesanoid | Tretinoin | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.